Subramanian Usha, Eckert George, Yeung Ada, Tierney William M
Roudebush VAMC, Indiana University School of Medicine, Indianapolis, IN, USA.
J Clin Epidemiol. 2007 Aug;60(8):803-11. doi: 10.1016/j.jclinepi.2006.11.007. Epub 2007 Mar 26.
Health status is an important marker of the impact of disease on function among patients with chronic heart failure (CHF). However, the prognostic value of CHF-specific health status on long-term mortality has not been adequately evaluated. Our objective was to assess CHF-specific health status and 5-year mortality among outpatients with CHF.
We analyzed data from 494 Veterans Affairs outpatients with diagnoses of CHF and objective evidence of left ventricular dysfunction who enrolled in a quality improvement intervention. We extracted information about comorbid diagnoses, severity of illness (Charlson index), health care utilization, drug therapy, laboratory, and vital sign data along with generic and CHF-specific health status. We then identified multivariate correlates of subsequent mortality at 5 years.
Five-year mortality was 44%. Age (chi2=26.1, hazard ratio [HR]=1.63, confidence interval [CI]: 1.35, 1.97; P<0.0001) and Charlson index (chi2=12.9, HR=1.39, CI: 1.16, 1.67; P=0.0003) were significantly associated with 5-year mortality. Controlling for clinical, lab, medication, and administrative data, a single-item assessing change in CHF-specific health status was independently associated with 5-year mortality (chi2=11.4, HR=0.87, CI: 0.80, 0.94, P=0.0007).
Given the strength of the association with mortality, health care providers should routinely assess this single-item change in health status among outpatients with CHF to identify higher risk patients and guide therapy.
健康状况是慢性心力衰竭(CHF)患者疾病对功能影响的重要指标。然而,CHF特异性健康状况对长期死亡率的预后价值尚未得到充分评估。我们的目的是评估CHF门诊患者的CHF特异性健康状况和5年死亡率。
我们分析了494名诊断为CHF且有左心室功能障碍客观证据的退伍军人事务门诊患者的数据,这些患者参加了一项质量改进干预。我们提取了有关合并诊断、疾病严重程度(Charlson指数)、医疗保健利用、药物治疗、实验室和生命体征数据以及一般和CHF特异性健康状况的信息。然后我们确定了5年后后续死亡率的多变量相关性。
5年死亡率为44%。年龄(χ²=26.1,风险比[HR]=1.63,置信区间[CI]:1.35,1.97;P<0.0001)和Charlson指数(χ²=12.9,HR=1.39,CI:1.16,1.67;P=0.0003)与5年死亡率显著相关。在控制临床、实验室、药物和管理数据后,一项评估CHF特异性健康状况变化的单项指标与5年死亡率独立相关(χ²=11.4,HR=0.87,CI:0.80,0.94,P=0.0007)。
鉴于与死亡率的关联强度,医疗保健提供者应常规评估CHF门诊患者健康状况的这一单项变化,以识别高风险患者并指导治疗。